000 | 01695 a2200517 4500 | ||
---|---|---|---|
005 | 20250512003002.0 | ||
264 | 0 | _c19900118 | |
008 | 199001s 0 0 fre d | ||
022 | _a0755-4982 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDesablens, B | |
245 | 0 | 0 |
_a[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol]. _h[electronic resource] |
260 |
_bPresse medicale (Paris, France : 1983) _cNov 1989 |
||
300 |
_a1917-21 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBleomycin _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDacarbazine _xtherapeutic use |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
650 | 0 | 4 | _aRadiation Dosage |
650 | 0 | 4 | _aVinblastine |
650 | 0 | 4 |
_aVincristine _xtherapeutic use |
700 | 1 | _aTourani, J M | |
700 | 1 | _aCasassus, P | |
700 | 1 | _aBrière, J | |
700 | 1 | _aHarousseau, J L | |
700 | 1 | _aLemevel, A | |
700 | 1 | _aIfrah, N | |
700 | 1 | _aLe Prise, P Y | |
700 | 1 | _aGandhour, C | |
700 | 1 | _aGuilhot, F | |
773 | 0 |
_tPresse medicale (Paris, France : 1983) _gvol. 18 _gno. 39 _gp. 1917-21 |
|
999 |
_c2486597 _d2486597 |